Corbus Pharmaceuticals Holdings Inc. rises Wednesday and outperforms the market

by

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP,
+ 10.88%
Up 10.88% to $ 3.42 Wednesday, on what turned out to be an all-round mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA,
+ 0.20%
increases 0.20% to 31,437.80 and the NASDAQ Composite Index COMP,
-0.25%
decreased by 0.25% to 13,972.53. This was the stock’s third consecutive day of earnings. Corbus Pharmaceuticals Holdings Inc. closed at $ 6.37 below its 52-week high ($ 9.78) the company hit on Aug. 31.

The stock outperformed some of its competitors on Wednesday, such as Fate Therapeutics Inc. FATE,
-1.91%
fell 1.91% to $ 103.31, Vanda Pharmaceuticals Inc. VNDA,
-0.58%
fell 0.58% to $ 15.41 and Viking Therapeutics Inc. VKTX,
-2.09%
decreased 2.09% to $ 8.89. The trading volume (66.0 million) eclipsed the 50-day average volume of 12.8 million.

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.

.Source